Exact Mass: 400.2488
Exact Mass Matches: 400.2488
Found 500 metabolites which its exact mass value is equals to given mass value 400.2488
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
16alpha,17-Isopropylidenedioxy-6alpha-methylprogesterone
11'-Carboxy-gamma-tocotrienol
11-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 11-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. Gamma-tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. Gamma-tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. 11-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 11-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate
Colupulone
Colupulone is found in alcoholic beverages. Colupulone is a constituent of the resin of English hops
Ajulemic acid
Cochliobolin A
Nocloprost
(6Ar,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,9,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid
MG(5-iso PGF2VI/0:0/0:0)
MG(5-iso PGF2VI/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/5-iso PGF2VI/0:0)
MG(0:0/5-iso PGF2VI/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
Aplysinoplide A
A sesterterpenoid isolated from the marine sponge Aplysinopsis digitata that exhibits cytotoxicity against P388 mouse leukemia cells.
23,24,25,26,27-Pentanor-3,7-dioxocucurbit-5-en-22-oic acid
10-O-beta-D-glucopyranosideoplopanone|oplopanone-8-O-beta-D-glucopyranoside
18-Angeloyl 鈥樎?ent-3beta,4alphaH)-15,16-Epoxy-7,13(16),14-clerodatriene-3,18-diol
1-O-isopropyl-6-O-(5,9-dimethyl-2,8-decadienoyl)-beta-D-glucopyranoside|citrusoside A
Solidagolactone III
[(1R,3R,4R,4aS,8aR)-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2H-furan-3-yl)ethyl]-1,2,3,4a,5,6-hexahydronaphthalen-1-yl] (E)-2-methylbut-2-enoate is a natural product found in Solidago virgaurea with data available.
ent-3beta-(3-methyl-2-butenoyloxy)-15-beyeren-19-oic acid
elasclepic acid|ent-14beta-tygloyloxybeyer-15-ene-19-oic acid
15alpha-angeloyloxykaur-16-en-19-oic acid|15alpha-tiglinoyloxy-ent-kaurenic acid|15alpha-tiglinoyloxy-ent-kaurenoic acid|15alpha-tigloyloxy-ent-kaur-16-en-19-oic acid
24-Methyl-25-nor-12,24-dioxo-16-scalaren-22-oic acid
1(R),4beta-dihydroxy-trans-eudesm-6-ene-1-O-beta-D-glucopyranoside
3beta,11-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside A
5-[13-(3-Furanyl)-2, 6, 10-trimethyl-3, 5-tridecadienyl]-4-hydroxy-3-methyl-2(5H)-furanone|7,8-Dihydroisopalinurin
3beta-[(beta-D-glucopyranosyl)oxy]eudesm-4(14)-en-11-ol
15alpha-senecioyloxy-ent-kaurenic acid|ent-15beta-senecioyloxy-kaur-16-en-19-oic acid
16-methoxy-1-propionyl-aspidospermidine-17,21-diol|16-methoxy-limaspermine|3-Methoxy-limaspermin
(ent-15beta)-Angeloyl-15-Hydroxy-16-kauren-19-oic acid|(ent-15beta)-Tigloyl-15-Hydroxy-16-kauren-19-oic acid|Angeloyl-15-Hydroxy-16-kauren-19-oic acid|Tigloyl-15-Hydroxy-16-kauren-19-oic acid
1alpha,6beta-dihydroxy-5,10-bis-epi-eudesm-4(15)-ene-6-O-beta-D-glucopyranoside|funingensin A
7-drimen-3beta-,11-diol 3-O-beta-D-glucopyranoside
3alpha-hydroxypatchoulol 3-O-beta-D-glucopyranoside
14-[((2Z)-2-methylbut-2-enoyl)oxy]-3,4-seco-ent-kaura-4(19),16-dien-3-oic acid
(2R*,5S*,7R*,10S*)-7-hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
3beta,19-diacetoxypregna-5,20-diene|sclerosteroid B
1beta-hydroxy-3-oxo-4beta,5alpha,7alpha-H-eudesmane 11-O-alpha-L-rhamnopyranoside
2,7,11-trihydroxybisabola-1(15),9-diene 7-beta-D-fucopyranoside
(3beta,5beta,14beta,16beta,20Z)-16-acetoxy-14,21-epoxy-24-norcholan-20,22-dien-3-ol
2,7,10-trihydroxybisabola-1(15),11-diene 7-beta-D-fucopyranoside
19-Carboxylic acid,3-(3-methyl-2-butenoyl)-(ent-3beta)-16-Kaurene-3,19-diol
(5S,6E)-5-beta-D-glucopyranosyloxy-3-hydroxy-3,7,11-trimethyldodeca-1,6,10-triene|amarantholidoside III
3beta,11-dihydroxy-drim-8(12)-en-3-O-beta-D-glucopyranoside|xianglinmaojueside B
3alpha,16beta-dihydroxy-5alpha-pregna-1,20-diene 3,16-diacetate|Di-Ac-Pregna-1,20-diene-3,16-diol
(ent-15alpha)-3-Methyl-2-butenoyl-15-Hydroxy-16-kauren-19-oic acid|15-Hydroxy-16-kauren-19-oic acid3-Methyl-2-butenoyl
1beta-(beta-D-glucopyranosyl)oxy-6alpha-hydroxyeudesman-4(15)-ene|1??-D-Glucopyranosyloxy-6??-hydroxyeudesman-4(15)-ene
1(R),4beta-dihydroxy-trans-eudesm-7-ene-1-O-beta-D-glucopyranoside|oplodiol 1-O-beta-D-glucopyranoside
5-<13-(furan-3-yl)-2,6,10-trimethyltrideca-6,8-dienyl>-4-hydroxy-3-methylfuran-2(5H)-one|5-[13-(3-Furanyl)-2, 6, 10-trimethyl-6, 8-tridecadienyl]-4-hydroxy-3-methyl-2(5H)-furanone|5-[13-(furan-3-yl)-2,6,10-trimethyltrideca-6,8-dienyl]-4-hydroxy-3-methylfuran-2(5H)-one
18-Senecionyloxy-ent-kaurensaeure|3-Methyl-2-butenoyl-ent-18-Hydroxy-16-kauren-19-oic acid
3alpha-hydroxy-18-angeloyloxy-13-furyl-ent-labda-8(17)-ene
3alpha-angeloyloxy-15,16-epoxycleistanth-12-en-11-one
11,14-dihydroxy-drim-8(12)-en-11-O-beta-D-glucopyranoside|xianglinmaojueside C
Colupulone
Colupulone is a beta-bitter acid in which the acyl group is specified as isobutanoyl. It is a conjugate acid of a colupulone(1-). Colupulone is a natural product found in Humulus lupulus with data available. A beta-bitter acid in which the acyl group is specified as isobutanoyl.
phenyl-acetic acid 9-hydroxymethyl-7-(6-oxo-piperidin-2-yl)-octahydro-quinolizin-2-yl ester
Solidagolactone II
Elongatolide C is a natural product found in Solidago virgaurea with data available.
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based on: CCMSLIB00000846078]
2-[5-[2-[2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyloxy]propyl]oxolan-2-yl]propanoic acid [IIN-based: Match]
Ala Ile Pro Thr
Ala Ile Thr Pro
Ala Leu Pro Thr
Ala Leu Thr Pro
Ala Pro Ile Thr
Ala Pro Leu Thr
Ala Pro Thr Ile
Ala Pro Thr Leu
Ala Thr Ile Pro
Ala Thr Leu Pro
Ala Thr Pro Ile
Ala Thr Pro Leu
Ile Ala Pro Thr
Ile Ala Thr Pro
Ile Pro Ala Thr
Ile Pro Thr Ala
Ile Thr Ala Pro
Ile Thr Pro Ala
Leu Ala Pro Thr
Leu Ala Thr Pro
Leu Pro Ala Thr
Pro Ala Thr Leu
Pro Ile Ala Thr
Pro Ile Thr Ala
Pro Leu Ala Thr
Pro Leu Thr Ala
Pro Ser Val Val
Pro Thr Ala Ile
Pro Thr Ala Leu
Pro Thr Ile Ala
Pro Thr Leu Ala
Pro Val Ser Val
Pro Val Val Ser
Ser Pro Val Val
Ser Val Pro Val
Ser Val Val Pro
Thr Ala Ile Pro
Thr Ala Leu Pro
Thr Ala Pro Ile
Thr Ala Pro Leu
Thr Ile Ala Pro
Thr Leu Ala Pro
Thr Leu Pro Ala
Thr Pro Ala Ile
Thr Pro Ala Leu
Thr Pro Ile Ala
Thr Pro Leu Ala
Val Pro Ser Val
Val Pro Val Ser
Val Ser Pro Val
Val Ser Val Pro
Val Val Pro Ser
Val Val Ser Pro
2,2,2,2-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetamide
Lenabasum
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D063385 - Cannabinoid Receptor Modulators D018377 - Neurotransmitter Agents > D063385 - Cannabinoid Receptor Modulators > D063386 - Cannabinoid Receptor Agonists C308 - Immunotherapeutic Agent
(1R,2S,3S,3S,4R,7S,8E,11R)-4-hydroxy-1,3,4-trimethyl-5-(2-methylprop-1-enyl)-6-oxospiro[oxolane-2,12-tricyclo[9.3.0.03,7]tetradec-8-ene]-8-carbaldehyde
(6Ar,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,9,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid
Rapivab
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AH - Neuraminidase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004791 - Enzyme Inhibitors
Amantadine sulfate
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent C93038 - Cation Channel Blocker
(15S)-15alpha-(3-Methyl-2-butenoyloxy)kaur-16-en-18-oic acid
2-[(1E,5E,7E,9R,10R,11E)-10-hydroxy-3,7,9,11-tetramethyltrideca-1,5,7,11-tetraenyl]-6-methoxy-3,5-dimethylpyran-4-one
Ala-Leu-Thr-Pro
A tetrapeptide composed of L-alanine, L-leucine, L-threonine, and L-proline units joined in sequence.
2,4-dioxo-3-pentyl-N-[3-(1-piperidinyl)propyl]-1H-quinazoline-7-carboxamide
rel-(2R,5S,7R,10S)-7-Hydroperoxy-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-10-methyl-6-methylenespiro[4.5]-decane
A natural product found in Carthamus oxyacantha.
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
(3R)-farnesyl-6-hydroxy-2,3,5-trimethyl-4-oxocyclohexa-1,5-diene-1-carboxylic acid
A sesterterpenoid that is 4-oxocyclohexa-1,5-diene-1-carboxylic acid carrying three additional methyl substituents at positions 2, 3 and 5 as well as farnsyl and hydroxy substituents at positions 3 and 6 respectively. An intermediate in the biosynthesis of terretonin.
4-[(2r)-5-{2-[(1s,2s,8ar)-1,2,5,5-tetramethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5-hydroxy-5h-furan-2-one
2-[(5-hydroxy-2-isopropyl-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxypropyl]oxolan-2-yl]propanoyl]oxy}butyl]oxolan-2-yl]propanoic acid
(5s)-4-[(3e,7e)-4,8-dimethyl-10-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5-hydroxy-5h-furan-2-one
5,9-dimethyl-6-[(2-methylbut-2-enoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(5r)-4-[(2s)-5-{2-[(1r,2r,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5-hydroxy-5h-furan-2-one
5-hydroxy-4-{5-[2-(1,2,5,5-tetramethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl)ethyl]-3,6-dihydro-2h-pyran-2-yl}-5h-furan-2-one
(1e)-2-[(1s,2r,3s,9s)-3,9-dimethyl-3-(4-methylpent-3-en-1-yl)-8,12-dioxatricyclo[7.2.1.0¹,⁶]dodec-5-en-2-yl]ethenyl 3-methylbut-2-enoate
(5r)-5-[(2r,5e,9e)-13-(furan-3-yl)-2,6,10-trimethyltrideca-5,9-dien-1-yl]-4-hydroxy-3-methyl-5h-furan-2-one
(2r,5s,6s,9r,13s,15r)-6-[(2r,3r,4e)-2,3-dihydroxyhex-4-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one
(2s,3r,4s,5r,6r)-2-({2-[(2r,5r,7r,10r)-7-hydroperoxy-10-methyl-6-methylidenespiro[4.5]decan-2-yl]propan-2-yl}oxy)-6-methyloxane-3,4,5-triol
(1'r,2s,3s,3'r,5r,7'r,9's,10'e)-9'-hydroxy-10'-(hydroxymethyl)-3,3',14'-trimethyl-5-(2-methylprop-1-en-1-yl)spiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-10',13'-dien-12'-one
(3s,4s,7z)-7-[(4e,8e)-11-(furan-3-yl)-4,8-dimethylundeca-4,8-dien-1-ylidene]-4-hydroxy-3-methyloxocan-2-one
5-hydroxy-4-[(1e)-5-hydroxy-4-[4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]penta-1,3-dien-1-yl]-5h-furan-2-one
2-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-4-[3-(hydroxymethyl)-5-oxo-2h-furan-2-yl]but-2-enal
4-hydroxy-6-methyl-7-(3-methylbut-2-en-1-yl)-6-(4-methylpent-3-en-1-yl)-3-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione
(2r,3s,4e,6e)-7-[(1ar,2r,3s,3as,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-1a,6-dimethyl-2h,3h,3ah,4h,7h,7ah,7bh-naphtho[1,2-b]oxiren-3-yl]-3-hydroxy-2,4-dimethylhepta-4,6-dienoic acid
9-methyl-5-{[(2-methylbut-2-enoyl)oxy]methyl}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(1r,2s,3as,3bs,5as,7s,9ar,9bs,11as)-7-(acetyloxy)-1-ethenyl-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate
(1s,4s,5r,9s,10r,12r,13r)-5,9-dimethyl-12-{[(2z)-2-methylbut-2-enoyl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-1,2,3,4a,5,6-hexahydronaphthalen-1-yl 2-methylbut-2-enoate
(5r)-4-[(2r)-5-{2-[(1as,4ar,5s,6s,8as)-1a,5,6-trimethyl-octahydrocyclopropa[e]naphthalen-5-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5-hydroxy-5h-furan-2-one
(2r,5r,6r,9r,13s,15r)-6-[(2e,4r,5r)-4,5-dihydroxyhex-2-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one
(2r,5s,9r,13s,15s)-6-[(3e,5s)-2,5-dihydroxyhex-3-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one
2-(hydroxymethyl)-6-{[5-(hydroxymethyl)-1,1,4a-trimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl]oxy}oxane-3,4,5-triol
(1s,2s,3e,5r,7e,11r)-8-(hydroxymethyl)-1,5-dimethyl-5-[(2e)-4-methylpenta-2,4-dien-1-yl]-12-oxabicyclo[9.1.0]dodeca-3,7-dien-2-yl 3-methylbut-2-enoate
(1'r,2s,3s,3'r,5r,7'r,10'z)-5-[(1e)-3-hydroxy-2-methylprop-1-en-1-yl]-10'-(hydroxymethyl)-3,3',14'-trimethylspiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-10',13'-dien-12'-one
(2r,3r,4s,5r,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-4,8a-dimethyl-6-(propan-2-ylidene)-hexahydro-1h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,2r,4as,5r,8as)-5-[2-(furan-3-yl)ethyl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate
4-[(7e)-4,8-dimethyl-10-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)deca-3,7-dien-1-yl]-5-hydroxy-5h-furan-2-one
5-hydroxy-4-{5-hydroxy-4-[4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]penta-1,3-dien-1-yl}-5h-furan-2-one
(4s,5r,9s,10s,13s,15s)-5,9-dimethyl-15-{[(2z)-2-methylbut-2-enoyl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(2r)-2-[(2r,5s)-5-[(2s)-2-{[(2s)-2-[(2s,5r)-5-[(2r)-2-hydroxybutyl]oxolan-2-yl]propanoyl]oxy}propyl]oxolan-2-yl]propanoic acid
(5r)-4-[(2r)-5-{2-[(1s,2s,8ar)-1,2,5,5-tetramethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-3,6-dihydro-2h-pyran-2-yl]-5-hydroxy-5h-furan-2-one
(1r,3s,7r,8e,11s,12r)-12-[(2s,3z,5s)-5,6-dihydroxy-6-methylhept-3-en-2-yl]-1,4-dimethyl-6-oxotricyclo[9.3.0.0³,⁷]tetradeca-4,8-diene-8-carbaldehyde
(2r,5s,6s,9r,13s,15r)-6-[(2r,3s,4e)-2,3-dihydroxyhex-4-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one
(2r,3r,4s,5s,6r)-2-{[(1ar,3as,4s,7s,7as,7br)-7-hydroxy-1,1,3a,7-tetramethyl-octahydrocyclopropa[a]naphthalen-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,5s,6s,9r,13s,15s)-6-[(2s,3e,5r)-2,5-dihydroxyhex-3-en-2-yl]-15-hydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one
(1s,4s,5s,6r,9s,10r,13r)-5,9-dimethyl-6-{[(2e)-2-methylbut-2-enoyl]oxy}-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
5,9,13-trimethyl-16-[(2-methylbut-2-enoyl)oxy]tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-ene-5-carboxylic acid
(2s,3r,4s,5s,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-1,4a-dimethyl-7-(propan-2-ylidene)-hexahydro-2h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-[(3r)-3-hydroxy-3-(5-oxo-2h-furan-3-yl)propylidene]-6-methyl-8-(2,6,6-trimethylcyclohex-1-en-1-yl)oct-5-enal
(2s,3r,4s,5r,6r)-2-{[(1s,4s,4as,8as)-4-hydroxy-1,4a-dimethyl-7-(propan-2-ylidene)-hexahydro-2h-naphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,3r,3as,4as,5r,7ar,8r,8as)-8a-hydroxy-3,5,8-trimethyl-3-[2-(3-methylfuran-2-yl)ethyl]-1-(2-methylprop-1-en-1-yl)-octahydroindeno[5,6-c]furan-4-one
4-[(2r,6r)-6-hydroxy-5-[(3e)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]-3,6-dihydro-2h-pyran-2-yl]-5h-furan-2-one
(9'e)-15'-hydroxy-3,3',15'-trimethyl-5-(2-methylprop-1-en-1-yl)-12'-oxaspiro[oxolane-2,6'-tetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadecan]-9'-en-11'-one
1β-d-glucopyranosyloxy-6α-hydroxy-eudesman-4(15)-ene
{"Ingredient_id": "HBIN002393","Ingredient_name": "1\u03b2-d-glucopyranosyloxy-6\u03b1-hydroxy-eudesman-4(15)-ene","Alias": "NA","Ingredient_formula": "C21H36O7","Ingredient_Smile": "CC(C)C1CCC2(C(CCC(=C)C2C1O)OC3C(C(C(C(O3)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8691","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
atractyloside c
{"Ingredient_id": "HBIN017303","Ingredient_name": "atractyloside c","Alias": "NA","Ingredient_formula": "C21H36O7","Ingredient_Smile": "CC12CCC(CC1C(=C)CC(C2)O)C(C)(C)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "400.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14420","TCMID_id": "1976","TCMSP_id": "NA","TCM_ID_id": "6491","PubChem_id": "101831401","DrugBank_id": "NA"}